Ho Sung Kim
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma (NCT04143425) | Ho Sung Kim | 2020-02-06 |
Track Ho Sung Kim automatically
Every clearance here is in the API, with alerts when new ones post.